Lv51
1070 积分 2022-05-17 加入
The challenge of standardizing CAR‐T cell monitoring: A comparison of two flow‐cytometry methods and correlation with qPCR technique
2小时前
已完结
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B-cell lymphoma
5天前
已完结
Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large B-cell lymphoma therapy: A Meta-analysis
6天前
已完结
Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large B-cell lymphoma therapy: A Meta-analysis
6天前
已关闭
Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large B-cell lymphoma therapy: A Meta-analysis
6天前
已关闭
Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large B-cell lymphoma therapy: A Meta-analysis
6天前
已关闭
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
7天前
已完结
CAR T cells in autoimmune disease: On the road to remission
7天前
已完结
Beyond the blood: expanding CAR T cell therapy to solid tumors
10天前
已完结
Barriers to CAR T-cell therapy in rheumatology
10天前
已关闭
皖公网安备34019202002308
